Category: Investment

PhiSkin is a leading aesthetic medical clinic chain targeting mid-to-high-end customers in Beijing, Shanghai and other top tier cities in China. PhiSkin was founded in 2012 and is headquartered in Shanghai. As of today, PhiSkin has six clinics in operation across four cities – three in Shanghai, and one each in Beijing, Hangzhou, and Ningbo.

Instead of traditional plastic surgeries which typically require higher cost and a longer recovery period, Phiskin practices non- and minimal invasive treatments, notably thread lift, lower eyelid blepharoplasty and small-volume liposuction.

Seyond™, formerly Innovusion, is defined by devotion to its mission — to design, build, and mass produce the world’s highest-performing state-of-the-art LiDAR systems.

Headquartered in Silicon Valley, with additional facilities in Suzhou and Shanghai, Seyond represents the vanguard in long-range image-grade LiDAR and autonomous driving. Seyond’s technologies are enthusiastically embraced across automotive, smart transportation, rail transit, and industrial automation by industry leaders across the world.

Sinotau Pharmaceutical is an innovative pharmaceutical company focusing on the R&D, production and clinical application of a new generation of radiopharmaceuticals. Headquartered in Beijing, the company has set up radiopharmaceutical production bases in Jiangsu, Guangdong and Sichuan, and branches in the United States. Leveraging the world’s leading R&D resources in the field of radiopharmaceuticals and precision diagnosis and treatment, Sinotau has taken the lead in deploying a variety of targeted therapies and precision diagnostic radiopharmaceuticals in the fields of tumors, neurodegenerative diseases and cardiovascular diseases. The company’s pipeline has deployed multiple radiological diagnostic and therapeutic products, some of which have entered the stage of registered clinical research.

Taibang Biologic Group is a leading fully integrated plasma-based biopharmaceutical company in China. The company’s core capabilities include plasma collection, and the manufacturing and commercialization of human plasma-based biopharmaceutical products. These products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. As the company focuses on its plasma business, Taibang have expanded its product pipeline to include non-plasma biopharmaceutical products and bio-medical device products to complement its market position and expand its base of users in the growing core plasma therapeutic business.

UIB Healthcare Group is a leading pediatrics healthcare services provider with a primary focus in top-tier cities in China. The group currently owns and operates a number of hospitals and facilities in Beijing and Shanghai, including Beijing Jingdu Children’s Hospital, Shanghai Pubin Children’s Hospital and UIB International Maternity Care Center. With annual number of outpatient visits of 800,000 person-times, the group is one of the largest private hospital groups in China.

UIB Healthcare strives for the highest medical treatment standards and professional integrity, and takes pride in its highly-skilled medical team. Its facilities are leaders in treatment of specialties such as hematology, gastroenterology, cardiac surgery and children developmental behavior. For example, Beijing Jingdu Children’s Hospital has China’s largest hematology department and transplantation center.

Through continuous academic advancement across its core departments and improving its service quality, UIB Healthcare strives to become a first-class women’s and children’s healthcare brand in China, as well as a preferred platform for healthcare practitioners.

XPENG is a leading Chinese Smart EV company that designs, develops, manufactures, and markets Smart EVs that appeal to the large and growing base of technology-savvy middle-class consumers. Its mission is to drive Smart EV transformation with technology, shaping the mobility experience of the future. In order to optimize its customers’ mobility experience, XPENG develops in-house its full-stack advanced driver-assistance system technology and in-car intelligent operating system, as well as core vehicle systems including powertrain and the electrical/electronic architecture.

XPENG is headquartered in Guangzhou, China, with main offices in Beijing, Shanghai, Silicon Valley, San Diego and Amsterdam. The Company’s Smart EVs are mainly manufactured at its plants in Zhaoqing and Guangzhou, Guangdong province.

Yigoli is China’s first and leading AI-enabled high-tech car wash solution provider with over 3,000 car wash outlets covering most provinces in China, South Korea, Thailand and Indonesia. Leveraging its self-developed intelligent operation system, Yigoli offers one of the most efficient and environmentally- friendly car wash services for customers in China and abroad.